The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Overall survival in advanced GIST over time and correlation with access to post-imatinib tyrosine kinase inhibitors: Results from the Life Raft Group Registry.

Michael C.  Heinrich

Stock and Other Ownership Interests  - MolecularMD

Honoraria - Novartis

Consulting or Advisory Role - ARIAD; Bayer; Blueprint Medicines; Deciphera; MolecularMD; Novartis; Pfizer

Research Funding - ARIAD (Inst); Blueprint Medicines (Inst); Deciphera (Inst); Novartis (Inst)

Patents, Royalties, Other Intellectual Property - Patent on treatment of GIST-licensed to Novartis (Inst)

Expert Testimony - Novartis

Jerry  Call

Stock and Other Ownership Interests  - Blueprint Medicines

Research Funding - Blueprint Medicines (Inst)